Business Standard

BSE Healthcare index hits 52-week high, zooms 36% from March low

Dr Reddy's Laboratories, Cipla, and seven other frontline pharma stocks have hit their respective 52-week highs in the past one week

pharma, medicines, drugs
Premium

This is probably a beginning of the end of the sector's 5-year bear phase, analysts said

SI Reporter Mumbai
Shares of pharmaceutical companies continued their rally with the S&P BSE Healthcare index hitting fresh 52-week high on the BSE on the back of positive developments in the sector even as most brokerages don't see a meaningful adverse impact of coronavirus (COVID-19) lockdown on the companies' earnings.

The S&P BSE Healthcare index hit 52-week high of 14,854 points on Monday, surging 36 per cent in the last three weeks. In the last 12 trading days, the healthcare index has erased its entire losses of the year 2020. The index hit a 52-week low of 10,948, touched in intra-day trade

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in